Open AccessThe Effect of Exenatide on Thyroid-Stimulating Hormone and Thyroid Volume
Author(s) -
Muhammed Erkam Sencar,
Davut Sakız,
Murat Çalapkulu,
Sema Hepşen,
Muhammed Kızılgül,
Ilknur Unsal Ozturk,
Bekir Uçan,
Murat Bayram,
Büşra Betül Çağır,
Şafak Akın,
Mustafa Özbek
Publication year - 2019
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000501895
Subject(s) - medicine , exenatide , endocrinology , thyroid , hormone , thyroid stimulating hormone , calcitonin , diabetes mellitus , body mass index , thyroid disease , type 2 diabetes
Glucagon-like peptide-1 (GLP-1) analogues are now widely used for the treatment of type 2 diabetes mellitus (DM). Many binding sites for GLP-1 have been demonstrated in the specific tissue compartments of organs in-cluding the brain and thyroid. The aim of this study was to investigate the effect of exenatide treatment on thyroid-stimulating hormone (TSH) and thyroid volume in diabetic patients without thyroid disease.